GLB-001
A First-in-human, Phase 1, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
Near Add Your Location
Sorting 15 by
Center of Excellence
- Accepting patients
- Show Principal Investigator
Center of Excellence
- Accepting patients
Center of Excellence
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
AMR Kansas City Oncology
Merriam, KS
- Accepting patients
Center of Excellence
Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
- Accepting patients
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Roswell Park Cancer Institute
Buffalo, NY
- Accepting patients
Kadlec Clinic Hematology and Oncology
Kennewick, WA
- Accepting patients
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.